X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Americas

Chicago misses out in AbbVie-Calico pharma deal

Yuvraj_pawp by Yuvraj_pawp
6th September 2014
in Americas, News

A few days ago, Calico, a Google-backed biotech company, announced that it would build a California-based research and development facility to invent new drugs to combat diseases afflicting the elderly.

Half of the initial $500 million investment would be footed by AbbVie, a pharma company based in the Chicago area, for a few more months at least.

AbbVie’s CEO, Richard Gonzalez, and its board, which includes former United Airlines CEO Glenn Tilton, Northern Trust CEO Frederick Waddell and former Allstate CEO Edward Liddy, has made the unpopular decision to use its acquisition of European competitor Shire to move its headquarters to Ireland to lower its tax bill.

And now it also has decided to invest in a second California facility — presumably one not far from its existing research facility in Redwood City — rather than here, where its former parent company has roots dating to 1888.

That represents another missed opportunity for Chicago and Illinois, whose political leaders constantly tout the need for new research and development projects.

AbbVie defenders say this isn’t a loss. Profits will be split down the middle. AbbVie will take responsibility for testing and making the drugs that come out of Calico’s test tubes.

There’ll be plenty of “downstream opportunity” in Chicago, meaning after the scientific breakthrough occurs, said Michael Kope, CEO of the SENS Research Foundation, a Silicon Valley-based charity that works on cures for age-related diseases.

Downstream. That’s where Chicago aspires to be, right?

Consider the few research and development wins Chicago can tout in the last few years.

There was the $70 million grant over five years from the U.S. Department of Defense for a digital manufacturing lab. State and local governments kicked in $26 million more. And private companies made commitments that boosters claim brought the total to $320 million. (City officials have refused to disclose how much of that was in-kind vs. cash.)

There’s also a $120 million grant over five years from the U.S. Department of Energy for battery research at Argonne National Laboratory.

Compare that to Calico and AbbVie’s privately funded effort, which, if all goes well, will amount to a $1.5 billion investment.

The mayor’s office didn’t even know such a project was in play, even though one of AbbVie’s board members serves on the board of World Business Chicago, which is supposed to be this city’s corporate cheerleader-in-chief.

“AbbVie and Google have not discussed their plans with us,” said David Roeder, a spokesman for the state’s economic development agency. “As publicly traded companies, they have to be careful about disclosure of pending deals. News accounts indicate they plan to build in California. We are eager to discuss with them opportunities in Illinois.”

Biotech is a Bay Area strength, but the region hasn’t dominated the health care industry in the way it has the software and computing world. That is changing.

“The reality is that we’re seeing the consumerization of health care,” said Glen Tullman, the former Allscripts chief executive, whose Chicago-based 7wire Ventures invests in health care technology companies. “If you look at every other industry, the consumerization of those industries has by and large been led out of Silicon Valley. There’s a lot of talent out there that understands how to take everything from a basic service or an iPhone and apply them to health care.”

Data prepared by accounting firm EY for an industry trade group show that as of 2011, the biotech industry employed 230,177 people in California and 81,115 in Illinois. Research and development expenditures in 2010 in California amounted to $4.7 billion and in Illinois to $608 million.

Tags: AmericaChicago misses out in AbbVie-Calico pharma deal
Previous Post

Beacon Hill Launches New Division - Beacon Hill Pharma

Next Post

Halaven - Treatment of Metastatic Breast Cancer, Japan

Related Posts

Drug Development

New Delivery Path Brings To Light Efficacy of Immunotherapy

1st April 2023
Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform
Facilities & Operation

£277m Funding Set To Benefit UK Life Sciences Manufacturing

31st March 2023
Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Next Post

Halaven - Treatment of Metastatic Breast Cancer, Japan

Latest News

Drug Development

New Delivery Path Brings To Light Efficacy of Immunotherapy

1st April 2023
Cathay Cargo signs global airline partnership with Tower Cold Chain
Packaging & Logistic

Cathay Cargo signs global airline partnership with Tower Cold Chain

31st March 2023
Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform
Facilities & Operation

£277m Funding Set To Benefit UK Life Sciences Manufacturing

31st March 2023
Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In